BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3937284)

  • 21. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of labetalol on the arachidonic acid metabolism in human blood platelets, and in lung and aorta of the rat.
    Srivastava KC; Awasthi KK
    Prostaglandins Leukot Med; 1983 Sep; 12(1):1-9. PubMed ID: 6356152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Prostaglandins Leukot Med; 1985 Sep; 19(3):209-17. PubMed ID: 2865745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro enhancement of human platelet aggregation by somatostatin.
    Gazzaniga PP; Di Macco G; La Mancusa R; Oddi A; Pappalardo G; Pulcinelli FM; Reggio D
    Experientia; 1988 Oct; 44(10):892-4. PubMed ID: 2903069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet aggregation in whole blood by alcohol.
    Torres Duarte AP; Dong QS; Young J; Abi-Younes S; Myers AK
    Thromb Res; 1995 Apr; 78(2):107-15. PubMed ID: 7482428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
    Jackson ML; Searcy GP; Olexson DW
    Can J Comp Med; 1985 Jul; 49(3):271-7. PubMed ID: 3930056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
    Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
    Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some properties of mouse platelets.
    Rosenblum WI; Nelson GH; Cockrell CS; Ellis EF
    Thromb Res; 1983 May; 30(4):347-55. PubMed ID: 6412387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
    Pataricza J; Bor P; Szekeres L
    Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma.
    Knöfler R; Urano T; Malyszko J; Takada Y; Takada A
    Thromb Res; 1995 Jan; 77(1):69-78. PubMed ID: 7701479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
    Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
    Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood.
    Pattison A; Astley N; Eason CT; Bonner FW
    Thromb Res; 1990 Mar; 57(6):909-18. PubMed ID: 2116683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
    Iwamura M; Ishimori T; Makino M; Yasuda K; Izumi A; Himori N
    Jpn J Pharmacol; 1983 Feb; 33(1):219-26. PubMed ID: 6135813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.